Concepedia

Author

J. Oristrell

Deleted InstitutionORCID

Also Known As

J Oristrell, J. Oristrell, J. Oristrell Salvà, J. Oristrell Salvá, Joaquim Oristrell, Joaquim Oristrell Salvà, Joaquín Oristrell, Salvà, Joaquim Oristrell

69

Publications

2K

Citations

20

H-Index

81

Concepts

All Affiliations

Deleted InstitutionCorporació Sanitària Parc TaulíUniversitat Autònoma de BarcelonaHospital Clínic de BarcelonaUniversitat de Barcelona
JO

About

J. Oristrell is an author at Deleted Institution specializing in medicine, immunology, and vasculitis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

449

2

Public Health

4

4

195

3

Health Sciences

2

2

154

4

Allergy

1

1

21

5

Clinical Nutrition

1

1

125

J. Oristrell

×

26

Publications

1.8K

Citations

20

H-Index

YearCitations

The Persistent Exclusion of Older Patients From Ongoing Clinical Trials Regarding Heart Failure

Antonio Cherubini, J. Oristrell, Xavier Pla Barbero,

Archives of Internal Medicine

2011

359

Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis

María C. Cid, Carme Font, J. Oristrell,

Arthritis & Rheumatism

1998

286

Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides

Roser Soláns-Laqué, G. Fraile, Mónica Rodríguez‐Carballeira,

Medicine

2017

151

Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.

Manuel Ramos‐Casals, Francisco José García Hernández, E de Ramón,

PubMed

2010

140

Exclusion of Older People from Clinical Trials

Peter Crome, Frank Lally, Antonio Cherubini,

Drugs & Aging

2011

134

Vitamin D supplementation and COVID-19 risk: a population-based, cohort study

J. Oristrell, Joan Carles Oliva, E. Casado,

Journal of Endocrinological Investigation

2021

125

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label

Cándido Díaz‐Lagares, R. Pérez-Álvarez, Francisco José García Hernández,

Arthritis Research & Therapy

2011

70

Off-label use of rituximab for systemic lupus erythematosus in Europe

Monica Rydén‐Aulin, Dimitrios T. Boumpas, Irene E. M. Bultink,

Lupus Science & Medicine

2016

65

Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity

Blanca Coll‐Vinent, C. Vilardell, Carme Font,

Annals of the Rheumatic Diseases

1999

61

Reactive Perforating Collagenosis in Hodgkinʼs Disease

R Pedragosa, Hernando Knobel, P Huguet,

American Journal of Dermatopathology

1987

49

Page 1